Li M, Kirtane AR, Kiyokawa J, Nagashima H, et al. Local targeting of NAD+ salvage pathway alters the immune tumor microenvironment and enhances checkpoint immunotherapy in glioblastoma. Cancer Res 2020 Sep 30. pii: 0008-5472.CAN-20-1094.
PMID: 32998997